Neimeth International Pharmaceuticals Plc (NGSE: NEIMETH)
Health Care · Pharmaceuticals · NG
₦7.00
-6.04% today · +16.5% 1Y
Neimeth International Pharmaceuticals Plc (NGSE: NEIMETH) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $25.71M.
Over the last twelve months the share price has gained 16.5%, trading between 4.95 and 16.15.
Tweenvest scores Neimeth International Pharmaceuticals Plc across four factors: quality 56/100, value 40/100, growth 69/100. Its strongest factor is growth.
NEIMETH price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $25.71M
- Revenue (TTM)
- $5.88M
- P/E
- 30.52
- EPS
- 0.23
- Dividend yield
- —
- Beta (5Y)
- 0.67
- 52-week high
- ₦16.15
- 52-week low
- ₦4.95
- Avg volume (3M)
- —
- Shares outstanding
- 4.88B
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Winston Medical Supply Co., Ltd.TPEX: 6817 | $26.38M | NT$45.80 | -2.86% |
| Cessatech A/SNGM: CESSA | $26.25M | Dkr9.30 | +1.75% |
| Earth Science Tech, Inc.OTCPK: ETST | $26.23M | $0.09 | +0.11% |
| Korean Drug Co., Ltd.KOSDAQ: A014570 | $25.89M | ₩3,190.00 | -2.60% |
| MariMed Inc.OTCPK: MRMD | $25.53M | $0.06 | -8.19% |
| IRLAB Therapeutics AB (publ)OM: IRLAB A | $25.37M | Skr1.71 | -8.08% |
| Cilo Cybin Holdings LimitedJSE: CCC | $25.26M | R1.45 | -2.68% |
| MedRx Co., LtdTSE: 4586 | $25.10M | ¥58.00 | -1.69% |
Figures last refreshed Oct 11, 2026.